(Q70280716)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6352005%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6352005%20AND%20SRC:MED&resulttype=core&format=json

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

10 October 2019

main subject

phase III clinical trial

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

5 October 2023

author name string

J. Løber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6352005

5 October 2023

H. T. Mouridsen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6352005

5 October 2023

I. E. Christiansen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6352005

5 October 2023

P. Dombernowsky

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6352005

5 October 2023

W. Mattsson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6352005

5 October 2023

M. Rørth

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6352005

5 October 2023

language of work or name

English

0 references

publication date

1 November 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6352005%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

10 October 2019

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819831101%2952%3A9%3C1570%3A%3AAID-CNCR2820520905%3E3.0.CO%3B2-W

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6352005

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

5 October 2023

1 reference

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

5 October 2023

1 reference

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

5 October 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6352005%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6352005%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6352005%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

1570-1576

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6352005%20AND%20SRC:MED&resulttype=core&format=json

Studies on the toxicity and antitumour activity of prednimustine, a prednisolone ester of chlorambucil

10 October 2019

cites work

1

1 reference

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

Preliminary clinical and absorption studies with prednimustine in patients with mammary carcinoma

5 October 2023

2

1 reference

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

Cell killing effectiveness of an alkylating steroid (Leo 1031)

5 October 2023

3

1 reference

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

Mammary Tumour Inhibition and Subacute Toxicity in Rats of Prednimustine and of Its Molecular Components Chlorambucil and Prednisolone

5 October 2023

4

1 reference

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

Continuous treatment of non-Hodgkin's malignant lymphoma with prednimustine (Leo 1031)

5 October 2023

6

1 reference

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

5 October 2023

Cancer Treatment Reports

7

60

277

Kaufman

1976

1 reference

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

Prednimustine (NSC-134087, leo 1031) treatment of lymphocytic and lymphocytic-histiocytic lymphomas

5 October 2023

8

1 reference

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

Therapeutic effect of Leo 1031, an alkylating corticosteroid ester; in lymphoproliferative disorders. II. Lymphocytic lymphoma

5 October 2023

9

1 reference

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

Clinical trial of prednimustine, Leo-1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroids and alkylating agents

5 October 2023

10

1 reference

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

Therapeutic effect of Leo 1031, an alkylating corticosteroid ester, in lymphoproliferative disorders. I. chronic lymphocytic leukaemia

5 October 2023

11

1 reference

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer

5 October 2023

13

1 reference

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

5 October 2023

Cancer Treatment Reports

14

63

421

Johansson

1979

1 reference

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

Leo 1031 (NSC-134087) in gynecologic malignancies

5 October 2023

15

1 reference

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

Prednimustine Therapy for Advanced Prostatic Cancer

5 October 2023

16

1 reference

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

Secondary chemotherapy of advanced breast cancer

5 October 2023

17

1 reference

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

5 October 2023

20

1 reference

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

5 October 2023

Cancer Treatment Reports

22

66

2081

Boesen

1982

1 reference

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(19831101)52:9%3C1570::AID-CNCR2820520905%3E3.0.CO;2-W

5 October 2023

Identifiers

10.1002/1097-0142(19831101)52:9<1570::AID-CNCR2820520905>3.0.CO;2-W

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6352005%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference